CN108066613B - Pharmaceutical composition for treating gynecological postoperative low fever - Google Patents

Pharmaceutical composition for treating gynecological postoperative low fever Download PDF

Info

Publication number
CN108066613B
CN108066613B CN201810063899.XA CN201810063899A CN108066613B CN 108066613 B CN108066613 B CN 108066613B CN 201810063899 A CN201810063899 A CN 201810063899A CN 108066613 B CN108066613 B CN 108066613B
Authority
CN
China
Prior art keywords
parts
radix
pharmaceutical composition
low fever
extracting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201810063899.XA
Other languages
Chinese (zh)
Other versions
CN108066613A (en
Inventor
孟庆霞
李海莉
苏丽丽
邢鲁彦
张倩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201810063899.XA priority Critical patent/CN108066613B/en
Publication of CN108066613A publication Critical patent/CN108066613A/en
Application granted granted Critical
Publication of CN108066613B publication Critical patent/CN108066613B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8969—Polygonatum (Solomon's seal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/066—Clavicipitaceae
    • A61K36/068—Cordyceps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A61K36/195—Strobilanthes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233—Bupleurum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A61K36/315—Isatis, e.g. Dyer's woad
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489—Sophora, e.g. necklacepod or mamani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/638—Ligustrum, e.g. Chinese privet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725—Ziziphus, e.g. jujube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/808—Scrophularia (figwort)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/85—Verbenaceae (Verbena family)
    • A61K36/855—Clerodendrum, e.g. glorybower
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Abstract

The invention discloses a pharmaceutical composition for treating gynecological postoperative low fever, which comprises the following raw materials in parts by weight: 0.1-0.3 part of indometacin, 5-10 parts of honeysuckle, 8-16 parts of dandelion, 10-20 parts of folium isatidis, 3-8 parts of radix bupleuri, 3-8 parts of radix scrophulariae, 10-15 parts of Chinese date, 10-15 parts of wolfberry fruit, 5-10 parts of radix asparagi, 3-8 parts of glossy privet fruit, 2-6 parts of radix sophorae flavescentis, 3-8 parts of human placenta, 5-10 parts of rhizoma polygonati and 0.5-2.5 parts of cordyceps sinensis. The pharmaceutical composition provided by the invention has the effects of diminishing inflammation, relieving pain, clearing away heat and toxic materials, nourishing yin, reducing pathogenic fire, moistening dryness, promoting the production of body fluid, promoting blood circulation, removing blood stasis, tonifying qi, enriching blood, nourishing body and improving immunity, and has the advantages of obvious curative effect on low fever after gynecologic surgery, short treatment time, small dependence and low treatment cost.

Description

Pharmaceutical composition for treating gynecological postoperative low fever
Technical Field
The invention relates to the technical field of medicine research and development, in particular to a pharmaceutical composition for treating gynecological postoperative low fever.
Background
The gynecological postoperative low fever is one of the common diseases after gynecological operations, the clinical manifestations of the gynecological postoperative low fever are dizziness, palpitation, cough, hypodynamia, anorexia and the like, and the gynecological postoperative low fever is mostly caused by the postoperative immunity decline of patients, or the inflammation such as rheumatism, tuberculosis and the like, and finally the gynecological postoperative low fever causes the disorder or the damage of the body temperature nerve center. At present, the clinical treatment measures are usually antibiotic medicines, such as penicillin and second-generation cephalosporin, but the cost of the antibiotic medicines is high, and the long-term administration of the antibiotic medicines can generate medicine dependence. Therefore, more and more researchers turn to Chinese and western combined or pure Chinese medicinal preparations.
Chinese patent application publication no: CN 104922426A and CN 105497439A each disclose a pharmaceutical composition for treating gynecological postoperative low fever, and the pharmaceutical compositions provided by them are all compounded by a plurality of traditional Chinese medicinal materials, and tests prove that the pharmaceutical compositions have certain curative effect on gynecological postoperative low fever, the treatment period of the two generally needs 40 days, and the basic cure rate is only 30%, compared with the traditional western medicine treatment, the treatment period is overlong. Based on the above, the invention provides the pharmaceutical composition for treating the low fever after the gynecology and obstetrics operation, which has good treatment effect and quick treatment effect.
Disclosure of Invention
The invention aims to solve the defects in the prior art and provides a pharmaceutical composition for treating low fever after gynecology and obstetrics.
A pharmaceutical composition for treating gynecological postoperative low fever comprises the following raw materials in parts by weight: 0.1-0.3 part of indometacin, 5-10 parts of honeysuckle, 8-16 parts of dandelion, 10-20 parts of folium isatidis, 3-8 parts of radix bupleuri, 3-8 parts of radix scrophulariae, 10-15 parts of Chinese date, 10-15 parts of wolfberry fruit, 5-10 parts of radix asparagi, 3-8 parts of glossy privet fruit, 2-6 parts of radix sophorae flavescentis, 3-8 parts of human placenta, 5-10 parts of rhizoma polygonati and 0.5-2.5 parts of cordyceps sinensis.
Preferably, the pharmaceutical composition comprises the following raw materials in parts by weight: 0.2 part of indometacin, 8 parts of honeysuckle, 12 parts of dandelion, 15 parts of folium isatidis, 5 parts of radix bupleuri, 5 parts of radix scrophulariae, 13 parts of Chinese date, 13 parts of wolfberry fruit, 8 parts of radix asparagi, 5 parts of glossy privet fruit, 4 parts of radix sophorae flavescentis, 5 parts of human placenta, 8 parts of rhizoma polygonati and 1.5 parts of cordyceps sinensis.
Preferably, the pharmaceutical composition comprises the following raw materials in parts by weight: 0.2 part of indometacin, 0.1-0.3 part of indometacin, 6 parts of honeysuckle, 12 parts of dandelion, 14 parts of folium isatidis, 5 parts of radix bupleuri, 5 parts of radix scrophulariae, 12 parts of Chinese date, 14 parts of wolfberry fruit, 8 parts of radix asparagi, 6 parts of glossy privet fruit, 4 parts of radix sophorae flavescentis, 6 parts of placenta hominis, 8 parts of rhizoma polygonati and 2 parts of cordyceps sinensis.
Preferably, the pharmaceutical composition comprises the following raw materials in parts by weight: 0.2 part of indometacin, 7 parts of honeysuckle, 10 parts of dandelion, 14 parts of folium isatidis, 5 parts of radix bupleuri, 5 parts of radix scrophulariae, 12 parts of Chinese date, 12 parts of wolfberry fruit, 6 parts of radix asparagi, 5 parts of glossy privet fruit, 5 parts of radix sophorae flavescentis, 4 parts of human placenta, 8 parts of rhizoma polygonati and 1 part of cordyceps sinensis.
The invention also provides a preparation method of the pharmaceutical composition for treating gynecological postoperative low fever, which comprises the following steps:
s1, weighing the raw materials according to 0.2 part of indometacin, 5-10 parts of honeysuckle, 8-16 parts of dandelion, 10-20 parts of folium isatidis, 3-8 parts of radix bupleuri, 3-8 parts of radix scrophulariae, 10-15 parts of Chinese date, 10-15 parts of wolfberry fruit, 5-10 parts of radix asparagi, 3-8 parts of glossy privet fruit, 2-6 parts of radix sophorae flavescentis, 3-8 parts of human placenta, 5-10 parts of rhizoma polygonati and 0.5-2.5 parts of cordyceps sinensis for later use;
s2, putting the honeysuckle, the dandelion, the folium isatidis, the radix bupleuri, the radix asparagi, the glossy privet fruit, the placenta hominis and the rhizoma polygonati weighed in the step S1 into a grinder for grinding, sieving by a sieve of 10-18 meshes, respectively collecting sieved substances and oversize substances, extracting the sieved substances for 1-3 h by using a mixed solvent in an amount which is 8-12 times that of the sieved substances, extracting for 2 times by using water in an amount which is 6-10 times that of the sieved substances, extracting for 1-2 h each time, filtering after each extraction, combining filtrates, and concentrating under reduced pressure to obtain thick paste A for;
s3, combining the radix scrophulariae, the Chinese dates, the wolfberry fruits, the radix sophorae flavescentis weighed in the step S1 and the oversize products collected in the step S2, extracting the mixture for 2 times by using 8-10 times of ethanol, extracting the mixture for 1-2 hours each time, extracting the mixture for 1-2 hours by using 6-10 times of water, filtering the mixture after each extraction, combining the filtrates, concentrating the filtrate under reduced pressure and recovering the ethanol to obtain thick paste B for later use;
s4, grinding the cordyceps sinensis weighed in the step S1 into powder, mixing the powder with the thick paste A and the thick paste B, drying and then grinding to obtain the traditional Chinese medicine composition;
s5, mixing the indomethacin weighed in the step S1 with the traditional Chinese medicine composition prepared without S4, adding pharmaceutic adjuvants, drying, sieving, granulating, and preparing into a conventional dosage form to obtain the pharmaceutical composition for treating the low fever after the gynecologic surgery.
Preferably, the volume ratio of the mixed solvent is 4-5: 1, and the mass concentration of the ethanol is 55-65%.
The invention provides a pharmaceutical composition, which is prepared by extracting medicinal components from honeysuckle, dandelion, dyers woad leaf, radix bupleuri, radix scrophulariae, Chinese date, medlar, radix asparagi, glossy privet fruit, radix sophorae flavescentis, placenta hominis, rhizoma polygonati and cordyceps sinensis, and then treating low fever after gynecologic and obstetric surgery in cooperation with indomethacin, wherein the pharmaceutical composition prepared from thirteen traditional Chinese medicines and indomethacin has the effects of diminishing inflammation, relieving pain, clearing away heat and toxic materials, nourishing yin, reducing pathogenic fire, moistening dryness, promoting the production of body fluid, promoting blood circulation, removing blood stasis, tonifying qi, enriching blood, nourishing body and improving immunity, and the Chinese and western combined combination mode has the advantages of obvious curative effect, short treatment time, no need of long-time administration for patients, small pain and convenient administration, compared with pure western medicine treatment, small dependence, small toxic and side effects, low treatment cost, and aiming at the difficult-to-extract, pulverizing, sieving, extracting the sieved material with ethanol-diethyl ether mixed solvent and water, and extracting the sieved material, radix scrophulariae, fructus Jujubae, fructus Lycii and radix Sophorae Flavescentis with ethanol and water respectively to improve the extraction of effective components in the Chinese medicinal materials, improve the therapeutic effect of the pharmaceutical composition, and shorten the treatment period.
Detailed Description
The present invention will be further illustrated with reference to the following specific examples.
Example one
The invention provides a pharmaceutical composition for treating gynecological postoperative low fever, which comprises the following raw materials in parts by weight: 0.2 part of indometacin, 8 parts of honeysuckle, 12 parts of dandelion, 15 parts of folium isatidis, 5 parts of radix bupleuri, 5 parts of radix scrophulariae, 13 parts of Chinese date, 13 parts of wolfberry fruit, 8 parts of radix asparagi, 5 parts of glossy privet fruit, 4 parts of radix sophorae flavescentis, 5 parts of human placenta, 8 parts of rhizoma polygonati and 1.5 parts of cordyceps sinensis.
The preparation method comprises the following steps:
s1, weighing raw materials according to 0.2 part of indometacin, 8 parts of honeysuckle, 12 parts of dandelion, 15 parts of folium isatidis, 5 parts of radix bupleuri, 5 parts of radix scrophulariae, 13 parts of Chinese date, 13 parts of wolfberry fruit, 8 parts of radix asparagi, 5 parts of glossy privet fruit, 4 parts of radix sophorae flavescentis, 5 parts of human placenta, 8 parts of rhizoma polygonati and 1.5 parts of cordyceps sinensis for later use;
s2, putting the honeysuckle, the dandelion, the folium isatidis, the radix bupleuri, the radix asparagi, the glossy privet fruit, the human placenta and the rhizoma polygonati weighed in the step S1 into a grinder to be ground, sieving by a 14-mesh sieve, respectively collecting sieved substances and oversize substances, and mixing the sieved substances with the powder of the raw materials in a volume ratio of 10 times of 4: 1, extracting for 2h with 8 times of water for 2 times, each time for 1.5h, filtering after each extraction, mixing filtrates, and concentrating under reduced pressure to obtain soft extract A;
s3, combining the radix scrophulariae, the Chinese dates, the wolfberry fruits, the radix sophorae flavescentis weighed in the step S1 and the oversize products collected in the step S2, extracting for 2 times by 8 times of ethanol for 2 hours each time, extracting for 1.5 hours by 8 times of water for each time, filtering after each extraction, combining filtrates, concentrating under reduced pressure and recovering ethanol to obtain thick paste B for later use;
s4, grinding the cordyceps sinensis weighed in the step S1 into powder, mixing the powder with the thick paste A and the thick paste B, drying and then grinding to obtain the traditional Chinese medicine composition;
s5, mixing the indomethacin weighed in the step S1 with the traditional Chinese medicine composition prepared without S4, adding medicinal auxiliary materials, drying, sieving, granulating, and preparing into 200mg tablets to obtain the pharmaceutical composition for treating the low fever after the gynecologic surgery.
In the present invention, the mass concentration of ethanol is 60%.
Example two
The invention provides a pharmaceutical composition for treating gynecological postoperative low fever, which comprises the following raw materials in parts by weight: 0.2 part of indometacin, 6 parts of honeysuckle, 12 parts of dandelion, 14 parts of folium isatidis, 5 parts of radix bupleuri, 5 parts of radix scrophulariae, 12 parts of Chinese date, 14 parts of wolfberry fruit, 8 parts of radix asparagi, 6 parts of glossy privet fruit, 4 parts of radix sophorae flavescentis, 6 parts of human placenta, 8 parts of rhizoma polygonati and 2 parts of cordyceps sinensis.
The preparation method comprises the following steps:
s1, weighing raw materials according to 0.2 part of indometacin, 6 parts of honeysuckle, 12 parts of dandelion, 14 parts of folium isatidis, 5 parts of radix bupleuri, 5 parts of radix scrophulariae, 12 parts of Chinese date, 14 parts of wolfberry fruit, 8 parts of radix asparagi, 6 parts of glossy privet fruit, 4 parts of radix sophorae flavescentis, 6 parts of human placenta, 8 parts of rhizoma polygonati and 2 parts of cordyceps sinensis for later use;
s2, putting the honeysuckle, the dandelion, the folium isatidis, the radix bupleuri, the radix asparagi, the glossy privet fruit, the human placenta and the rhizoma polygonati weighed in the step S1 into a grinder to be ground, sieving by a 18-mesh sieve, respectively collecting sieved substances and oversize substances, wherein the volume ratio of the sieved substances to the oversize substances is 5: 1, extracting for 2 hours by using a mixture of ethanol and ether, extracting for 2 times by using 10 times of water for 1 hour each time, filtering after each extraction, combining filtrates, and concentrating under reduced pressure to obtain thick paste A for later use;
s3, combining the radix scrophulariae, the Chinese dates, the wolfberry fruits, the radix sophorae flavescentis weighed in the step S1 and the oversize products collected in the step S2, extracting for 2 times by 10 times of ethanol for 1 hour each time, extracting for 1 hour by 10 times of water for 1 hour each time, filtering after each extraction, combining filtrates, concentrating under reduced pressure and recovering ethanol to obtain thick paste B for later use;
s4, grinding the cordyceps sinensis weighed in the step S1 into powder, mixing the powder with the thick paste A and the thick paste B, drying and then grinding to obtain the traditional Chinese medicine composition;
s5, mixing the indomethacin weighed in the step S1 with the traditional Chinese medicine composition prepared without S4, adding medicinal auxiliary materials, drying, sieving, granulating, and preparing into 200mg granules to obtain the pharmaceutical composition for treating the low fever after the gynecologic surgery.
In the present invention, the mass concentration of ethanol is 65%.
EXAMPLE III
The invention provides a pharmaceutical composition for treating gynecological postoperative low fever, which comprises the following raw materials in parts by weight: 0.2 part of indometacin, 7 parts of honeysuckle, 10 parts of dandelion, 14 parts of folium isatidis, 5 parts of radix bupleuri, 5 parts of radix scrophulariae, 12 parts of Chinese date, 12 parts of wolfberry fruit, 6 parts of radix asparagi, 5 parts of glossy privet fruit, 5 parts of radix sophorae flavescentis, 4 parts of human placenta, 8 parts of rhizoma polygonati and 1 part of cordyceps sinensis.
The preparation method comprises the following steps:
s1, weighing raw materials according to 0.2 part of indometacin, 7 parts of honeysuckle, 10 parts of dandelion, 14 parts of folium isatidis, 5 parts of radix bupleuri, 5 parts of radix scrophulariae, 12 parts of Chinese date, 12 parts of wolfberry fruit, 6 parts of radix asparagi, 5 parts of glossy privet fruit, 5 parts of radix sophorae flavescentis, 4 parts of human placenta, 8 parts of rhizoma polygonati and 1 part of cordyceps sinensis for later use;
s2, putting the honeysuckle, the dandelion, the folium isatidis, the radix bupleuri, the radix asparagi, the glossy privet fruit, the human placenta and the rhizoma polygonati weighed in the step S1 into a grinder to be ground, sieving by a 10-mesh sieve, and respectively collecting sieved substances and oversize substances, wherein the volume ratio of the sieved substances to the oversize substances is 4: 1, extracting for 1h with a mixture of ethanol and diethyl ether, extracting with 6 times of water for 2 times, each time for 2h, filtering after each extraction, mixing filtrates, and concentrating under reduced pressure to obtain soft extract A;
s3, combining the radix scrophulariae, the Chinese dates, the wolfberry fruits, the radix sophorae flavescentis weighed in the step S1 and the oversize products collected in the step S2, extracting the mixture for 2 times by using 10 times of ethanol for 1 hour each time, extracting the mixture for 2 hours by using 6 times of water for 2 hours each time, filtering the mixture after each extraction, combining the filtrates, and concentrating the filtrate under reduced pressure to recover ethanol to obtain thick paste B for later use;
s4, grinding the cordyceps sinensis weighed in the step S1 into powder, mixing the powder with the thick paste A and the thick paste B, drying and then grinding to obtain the traditional Chinese medicine composition;
s5, mixing the indomethacin weighed in the step S1 with the traditional Chinese medicine composition prepared without S4, adding medicinal auxiliary materials, drying, sieving, granulating, and preparing into 200mg capsules to obtain the pharmaceutical composition for treating the low fever after the gynecologic surgery.
In the present invention, the mass concentration of ethanol is 55%.
Comparative example 1
The traditional Chinese medicine composition in the first embodiment is replaced by 0.2 part of indomethacin, and the pharmaceutical composition is prepared according to the preparation method in the first embodiment.
Comparative example No. two
Removing the indomethacin in the first embodiment, doubling the amount of the traditional Chinese medicine composition, and preparing the pharmaceutical composition according to the preparation method of the first embodiment.
The experiment on the treatment effect of the pharmaceutical composition on the low fever after the gynecology and obstetrics operation is as follows:
1. selection of cases
180 patients diagnosed with low fever after gynecologic surgery are selected, and the age is 26-54 years.
The cases were divided into 3 groups of 60 patients each, group 1 was treated with the pharmaceutical composition prepared in example one, group 2 was treated with the pharmaceutical composition prepared in comparative example one, group 3 was treated with the pharmaceutical composition prepared in comparative example two, and group 1, group 2 and group 3 were taken 2 times a day, one tablet at a time, 10 days as one treatment course, and 2 treatment courses were treated.
2. Criteria for efficacy assessment
The following evaluation criteria of therapeutic effects were made with reference to "criteria for diagnostic therapeutic effects of disorders of traditional Chinese medicine".
And (3) healing: the body temperature is normal, and symptoms disappear; the effect is shown: the body temperature returns to normal, and the symptoms basically disappear; the method has the following advantages: the body temperature is basically recovered to be normal, and the symptoms are basically disappeared; and (4) invalidation: no change in body temperature or disappearance of symptoms.
3. The curative effect results after 2 treatment courses are as follows:
recovery method Show effect Is effective Invalidation
Group 1 35(58.3％) 22(36.7％) 2(3.3％) 1(1.7％)
Group 2 8(13.3％) 10(16.7％) 18(30％) 24(40％)
Group 3 4(6.7％) 7(11.7％) 14(23.3％) 35(58.3％)
After 2 treatment courses, namely 20 days, the cure rate of the group 1 can reach 58.3%, which is obviously improved compared with 13.3% of the group 2 and 6.7% of the group 3, the total effective rate of the group 1 can reach 98.3%, while the effective rate of the group 2 is only 60%, and the effective rate of the group 3 is only 41.7%, which indicates that the traditional Chinese medicine composition in the medicine composition provided by the invention and indomethacin have the effect of synergistically treating the low fever after gynecologic surgery.
4. Typical case
After 2 treatment courses, the patient is subjected to a double-layered medical composition, and the patient is.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.

Claims (6)

1. A pharmaceutical composition for treating gynecological postoperative low fever is characterized by comprising the following raw materials in parts by weight: 0.1-0.3 part of indometacin, 5-10 parts of honeysuckle, 8-16 parts of dandelion, 10-20 parts of folium isatidis, 3-8 parts of radix bupleuri, 3-8 parts of radix scrophulariae, 10-15 parts of Chinese date, 10-15 parts of wolfberry fruit, 5-10 parts of radix asparagi, 3-8 parts of glossy privet fruit, 2-6 parts of radix sophorae flavescentis, 3-8 parts of human placenta, 5-10 parts of rhizoma polygonati and 0.5-2.5 parts of cordyceps sinensis.
2. The pharmaceutical composition for treating gynecological postoperative low fever disease according to claim 1, wherein the pharmaceutical composition comprises the following raw materials in parts by weight: 0.2 part of indometacin, 8 parts of honeysuckle, 12 parts of dandelion, 15 parts of folium isatidis, 5 parts of radix bupleuri, 5 parts of radix scrophulariae, 13 parts of Chinese date, 13 parts of wolfberry fruit, 8 parts of radix asparagi, 5 parts of glossy privet fruit, 4 parts of radix sophorae flavescentis, 5 parts of human placenta, 8 parts of rhizoma polygonati and 1.5 parts of cordyceps sinensis.
3. The pharmaceutical composition for treating gynecological postoperative low fever disease according to claim 1, wherein the pharmaceutical composition comprises the following raw materials in parts by weight: 0.2 part of indometacin, 6 parts of honeysuckle, 12 parts of dandelion, 14 parts of folium isatidis, 5 parts of radix bupleuri, 5 parts of radix scrophulariae, 12 parts of Chinese date, 14 parts of wolfberry fruit, 8 parts of radix asparagi, 6 parts of glossy privet fruit, 4 parts of radix sophorae flavescentis, 6 parts of human placenta, 8 parts of rhizoma polygonati and 2 parts of cordyceps sinensis.
4. The pharmaceutical composition for treating gynecological postoperative low fever disease according to claim 1, wherein the pharmaceutical composition comprises the following raw materials in parts by weight: 0.2 part of indometacin, 7 parts of honeysuckle, 10 parts of dandelion, 14 parts of folium isatidis, 5 parts of radix bupleuri, 5 parts of radix scrophulariae, 12 parts of Chinese date, 12 parts of wolfberry fruit, 6 parts of radix asparagi, 5 parts of glossy privet fruit, 5 parts of radix sophorae flavescentis, 4 parts of human placenta, 8 parts of rhizoma polygonati and 1 part of cordyceps sinensis.
5. The pharmaceutical composition for treating low fever after gynecology and obstetrics as claimed in claim 1, 2, 3 or 4, wherein the preparation method comprises the following steps:
s1, weighing the raw materials in parts by weight for later use;
s2, putting the honeysuckle, the dandelion, the folium isatidis, the radix bupleuri, the radix asparagi, the glossy privet fruit, the placenta hominis and the rhizoma polygonati weighed in the step S1 into a grinder for grinding, sieving by a sieve of 10-18 meshes, respectively collecting sieved substances and oversize substances, extracting the sieved substances for 1-3 h by using a mixed solvent in an amount which is 8-12 times that of the sieved substances, extracting for 2 times by using water in an amount which is 6-10 times that of the sieved substances, extracting for 1-2 h each time, filtering after each extraction, combining filtrates, and concentrating under reduced pressure to obtain thick paste A for;
s3, combining the radix scrophulariae, the Chinese dates, the wolfberry fruits, the radix sophorae flavescentis weighed in the step S1 and the oversize products collected in the step S2, extracting the mixture for 2 times by using 8-10 times of ethanol, extracting the mixture for 1-2 hours each time, extracting the mixture for 1-2 hours by using 6-10 times of water, filtering the mixture after each extraction, combining the filtrates, concentrating the filtrate under reduced pressure and recovering the ethanol to obtain thick paste B for later use;
s4, grinding the cordyceps sinensis weighed in the step S1 into powder, mixing the powder with the thick paste A and the thick paste B, drying and then grinding to obtain the traditional Chinese medicine composition;
s5, mixing the indomethacin weighed in the step S1 with the traditional Chinese medicine composition prepared in the step S4, adding pharmaceutic adjuvants, drying, sieving, granulating, and preparing into a conventional dosage form to obtain the pharmaceutical composition for treating the low fever after the gynecologic surgery.
6. The preparation method of the pharmaceutical composition for treating gynecological postoperative low fever according to claim 5, wherein the volume ratio of the mixed solvent is 4-5: 1, and the mass concentration of the ethanol is 55-65%.
CN201810063899.XA 2018-01-23 2018-01-23 Pharmaceutical composition for treating gynecological postoperative low fever Expired - Fee Related CN108066613B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810063899.XA CN108066613B (en) 2018-01-23 2018-01-23 Pharmaceutical composition for treating gynecological postoperative low fever

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810063899.XA CN108066613B (en) 2018-01-23 2018-01-23 Pharmaceutical composition for treating gynecological postoperative low fever

Publications (2)

Publication Number Publication Date
CN108066613A CN108066613A (en) 2018-05-25
CN108066613B true CN108066613B (en) 2021-01-05

Family

ID=62156761

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810063899.XA Expired - Fee Related CN108066613B (en) 2018-01-23 2018-01-23 Pharmaceutical composition for treating gynecological postoperative low fever

Country Status (1)

Country Link
CN (1) CN108066613B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1290534A (en) * 2000-03-09 2001-04-11 丛繁滋 Quick-acting spray composition for proverting cold and its preparing method
EP2700431A1 (en) * 2012-08-24 2014-02-26 AnalytiCon Discovery GmbH Plant extracts for modulating TRPV1 function
CN107496772A (en) * 2017-10-09 2017-12-22 宿淑平 A kind of pharmaceutical composition for treating post gynecologic operation low fever

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1290534A (en) * 2000-03-09 2001-04-11 丛繁滋 Quick-acting spray composition for proverting cold and its preparing method
EP2700431A1 (en) * 2012-08-24 2014-02-26 AnalytiCon Discovery GmbH Plant extracts for modulating TRPV1 function
CN107496772A (en) * 2017-10-09 2017-12-22 宿淑平 A kind of pharmaceutical composition for treating post gynecologic operation low fever

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
吲哚美辛治疗剖宫产术后发热50例疗效观察;魏亚平等;《苏州大学学报（医学版）》;20021231;第22卷(第5期);第612-613页 *

Also Published As

Publication number Publication date
CN108066613A (en) 2018-05-25

Similar Documents

Publication Publication Date Title
CN102048895B (en) Pure traditional Chinese medicine preparation for treating dilated cardiomyopathy
CN104225006A (en) Traditional Chinese medicine composition capable of invigorating Qi and relaxing bowels
CN112656877A (en) Pharmaceutical composition for treating cervical disc herniation and preparation method and application thereof
CN104055935A (en) Traditional Chinese medicine composition for improving immunity in synergetic mode
CN108066613B (en) Pharmaceutical composition for treating gynecological postoperative low fever
CN104257947A (en) Pharmaceutical composition for treating low fever caused by gynecological operation
CN106727892A (en) A kind of compound taxol preparation and preparation method thereof
CN111358860A (en) Traditional Chinese medicine composition for improving climacteric endocrine and preparation method and application thereof
CN102204956B (en) Chinese medicinal composition used at stroke recovery period and preparation method thereof
CN104784418A (en) Medicine for curing protrusion of lumbar intervertebral disc
CN107802676B (en) Lilac extract and preparation method and application thereof
CN112138105B (en) Traditional Chinese medicine composition for treating bronchiectasis lung-spleen qi deficiency and phlegm-damp lung blocking syndrome and application thereof
CN116474046B (en) Pharmaceutical composition for treating novel coronavirus infection, preparation method and application thereof
CN105435162B (en) Traditional Chinese medicine composition for treating allergic rhinitis, preparation method and traditional Chinese medicine preparation
US20190167731A1 (en) Traditional Chinese Medicine Composition for Treating Acute Stage of Cerebral Infarction
CN112076276B (en) Pharmaceutical composition for treating allergic rhinitis and preparation method thereof
CN113057994B (en) Patrinia scabiosaefolia active component, preparation method and application thereof
CN106138208A (en) A kind of application compress treating chronic skin ulcer and preparation method thereof
CN108653460B (en) Traditional Chinese medicine composition for treating chronic urticaria and preparation method thereof
CN104906360A (en) Traditional Chinese medicine compound capable of nourishing Yin and promoting blood circulation
CN101450133A (en) Medicine for treating abdominopelvic cavity disease postoperative intestinal adhesion
CN108938785B (en) Traditional Chinese medicine composition for treating cough variant asthma and preparation method thereof
CN106943506B (en) A pharmaceutical composition for treating climacteric syndrome, and its preparation method
CN116159112A (en) Pharmaceutical composition for preventing novel coronavirus infection, and preparation method and application thereof
CN115105480A (en) Agastache rugosus vital energy strengthening tablet and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20210105

Termination date: 20220123

CF01 Termination of patent right due to non-payment of annual fee